Last 47 quarters of trend data · Healthcare · Medical - Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 37.47 | 26.31 | 30.78 | 24.40 | 24.03 | 48.49 | 63.23 | 51.16 | 49.29 | 80.99 | 96.32 | 50.04 | 80.43 | 114.74 | 242.04 | 128.68 | 83.90 | 155.27 | 139.02 | — | 162.75 |
| — | -45.7% | -51.3% | -52.3% | -51.2% | -40.1% | -34.4% | +2.3% | -38.7% | -29.4% | -60.2% | -61.1% | -4.1% | -26.1% | +74.1% | — | -48.5% | +10.5% | -13.4% | — | +13.7% | |
| P/S Ratio | 6.48 | 5.04 | 5.18 | 5.25 | 5.67 | 7.70 | 6.72 | 7.10 | 6.92 | 11.76 | 15.69 | 12.47 | 10.21 | 15.91 | 16.39 | 14.79 | 11.14 | 11.28 | 21.80 | 18.65 | 22.62 |
| — | -34.5% | -22.8% | -26.0% | -18.0% | -34.6% | -57.2% | -43.1% | -32.3% | -26.1% | -4.3% | -15.7% | -8.3% | +41.1% | -24.8% | -20.7% | -50.7% | -41.1% | +17.2% | +17.7% | +10.5% | |
| P/B Ratio | 11.57 | 10.07 | 8.36 | 9.64 | 10.06 | 13.85 | 12.28 | 15.04 | 13.90 | 19.41 | 25.72 | 24.95 | 17.56 | 26.40 | 21.77 | 22.62 | 18.80 | 13.92 | 25.05 | 25.51 | 27.54 |
| — | -27.3% | -31.9% | -35.9% | -27.6% | -28.7% | -52.3% | -39.7% | -20.9% | -26.5% | +18.1% | +10.3% | -6.6% | +89.6% | -13.1% | -11.3% | -31.7% | -39.0% | +26.8% | +29.2% | +0.7% | |
| P/FCF | 28.06 | 35.76 | 13.76 | 34.45 | 11.83 | 42.64 | 71.87 | 44.72 | 77.86 | 55.39 | 94.87 | 159.09 | 45.50 | 105.58 | 150.62 | 174.74 | 46.34 | 96.58 | — | 508.64 | 105.65 |
| — | -16.1% | -80.9% | -23.0% | -84.8% | -23.0% | -24.2% | -71.9% | +71.1% | -47.5% | -37.0% | -9.0% | -1.8% | +9.3% | — | -65.6% | -56.1% | — | — | +531.0% | +3.2% | |
| EV / EBITDA | 26.38 | 17.26 | 19.37 | 17.35 | 22.99 | 33.61 | 38.08 | 34.06 | 35.54 | 58.20 | 96.90 | 49.77 | 41.28 | 83.86 | 141.16 | 76.89 | 47.84 | 68.01 | 180.12 | 406.65 | 103.03 |
| — | -48.7% | -49.1% | -49.0% | -35.3% | -42.3% | -60.7% | -31.6% | -13.9% | -30.6% | -31.4% | -35.3% | -13.7% | +23.3% | -21.6% | -81.1% | -53.6% | -26.9% | +24.3% | +445.9% | +10.0% | |
| EV / EBIT | 33.66 | 20.81 | 22.91 | 19.53 | 19.72 | 37.69 | 46.39 | 38.86 | 40.46 | 63.49 | 108.56 | 53.40 | 42.70 | 87.21 | 181.41 | 90.16 | 59.23 | 102.53 | 338.97 | 1197.98 | 125.24 |
| — | -44.8% | -50.6% | -49.7% | -51.3% | -40.6% | -57.3% | -27.2% | -5.2% | -27.2% | -40.2% | -40.8% | -27.9% | -14.9% | -46.5% | -92.5% | -52.7% | -9.8% | +61.0% | +1269.0% | +18.2% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 60.0% | 63.4% | 62.9% | 62.9% | 61.8% | 59.5% | 56.9% | 58.9% | 59.7% | 62.4% | 61.0% | 63.5% | 63.9% | 62.7% | 62.4% | 66.4% | 64.2% | 64.6% | 63.3% | 67.7% | 68.7% |
| — | +6.6% | +10.7% | +6.9% | +3.5% | -4.6% | -6.8% | -7.2% | -6.6% | -0.5% | -2.2% | -4.4% | -0.4% | -2.9% | -1.5% | -1.9% | -6.6% | -7.9% | -7.0% | -3.5% | +1.1% | |
| Operating Margin | 19.6% | 24.3% | 21.4% | 25.6% | 20.1% | 18.4% | 12.9% | 17.0% | 15.3% | 15.7% | 11.0% | 21.0% | 21.1% | 14.7% | 6.4% | 15.4% | 19.2% | 11.1% | 6.6% | 0.1% | 18.2% |
| — | +32.4% | +66.0% | +51.2% | +31.2% | +16.8% | +17.6% | -19.1% | -27.5% | +7.0% | +72.4% | +36.3% | +10.0% | +32.9% | -3.1% | +17807.7% | +5.3% | -34.8% | -27.7% | -99.5% | -3.2% | |
| Net Margin | 17.9% | 19.0% | 16.7% | 21.2% | 23.5% | 15.5% | 10.2% | 13.6% | 13.5% | 14.3% | 15.9% | 24.8% | 12.4% | 13.3% | 6.6% | 11.3% | 13.1% | 7.3% | 15.5% | -2.8% | 10.9% |
| — | +22.5% | +64.5% | +55.8% | +73.3% | +8.7% | -36.0% | -45.0% | +9.4% | +7.4% | +142.5% | +120.0% | -5.9% | +81.9% | -57.6% | +505.3% | +20.6% | -30.8% | +93.9% | -104.5% | -24.3% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 34.5% | 8.9% | 7.0% | 9.8% | 10.7% | 7.4% | 4.8% | 7.4% | 6.1% | 6.1% | 6.8% | 11.8% | 5.5% | 5.3% | 2.2% | 4.6% | 5.0% | 2.3% | 4.6% | -0.9% | 3.4% |
| — | +20.2% | +45.0% | +31.4% | +75.6% | +21.2% | -28.9% | -37.1% | +10.4% | +14.6% | +204.7% | +154.7% | +11.4% | +133.6% | -51.6% | +599.8% | +44.6% | -29.0% | +112.8% | -104.3% | -32.2% | |
| ROA | 13.0% | 3.8% | 3.1% | 3.9% | 3.8% | 2.6% | 1.6% | 2.4% | 2.0% | 2.2% | 2.3% | 4.0% | 1.8% | 1.9% | 0.9% | 1.8% | 2.0% | 1.0% | 1.9% | -0.4% | 1.5% |
| — | +49.0% | +93.1% | +63.5% | +87.0% | +18.2% | -30.7% | -40.7% | +13.8% | +15.0% | +157.8% | +123.4% | -10.1% | +89.6% | -54.3% | +546.5% | +30.9% | -30.0% | +109.8% | -104.6% | -22.2% | |
| ROIC | 18.7% | 7.8% | 5.9% | 7.2% | 4.9% | 4.0% | 2.5% | 3.5% | 2.8% | 2.9% | 1.9% | 3.9% | 3.6% | 2.4% | 1.0% | 2.7% | 3.2% | 1.6% | 0.9% | 0.0% | 3.3% |
| — | +93.6% | +138.0% | +105.5% | +71.9% | +36.9% | +33.1% | -8.5% | -20.7% | +22.6% | +95.8% | +41.3% | +11.8% | +50.7% | +4.6% | +17280.9% | -4.3% | -39.5% | -21.6% | -99.4% | +23.9% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.51 | 0.53 | 0.47 | 0.51 | 0.94 | 1.00 | 1.14 | 1.23 | 1.31 | 1.07 | 1.15 | 1.25 | 1.20 | 1.61 | 0.96 | 1.01 | 1.17 | 0.95 | 0.98 | 1.06 | 0.88 |
| — | -46.8% | -58.9% | -58.9% | -27.8% | -5.9% | -1.1% | -1.9% | +9.2% | -33.6% | +20.1% | +24.6% | +2.6% | +69.4% | -1.9% | -4.8% | +32.5% | -0.1% | -0.6% | +4.9% | -27.3% | |
| Debt / EBITDA | 1.19 | 3.62 | 4.30 | 3.58 | 8.41 | 9.36 | 13.34 | 10.49 | 12.50 | 12.35 | 16.86 | 9.63 | 10.72 | 19.63 | 24.13 | 13.27 | 11.42 | 17.72 | 27.42 | 65.99 | 13.10 |
| — | -61.3% | -67.8% | -65.9% | -32.7% | -24.2% | -20.9% | +8.9% | +16.6% | -37.1% | -30.1% | -27.4% | -6.2% | +10.7% | -12.0% | -79.9% | -12.8% | +16.5% | -2.2% | +346.3% | -19.0% | |
| Current Ratio | 1.88 | 1.73 | 1.95 | 1.88 | 1.56 | 1.52 | 1.50 | 1.47 | 2.46 | 2.82 | 2.90 | 2.84 | 2.80 | 2.42 | 2.02 | 1.99 | 3.77 | 4.72 | 5.27 | 5.11 | 4.98 |
| — | +14.0% | +29.9% | +28.3% | -36.3% | -46.0% | -48.3% | -48.4% | -12.2% | +16.5% | +43.5% | +42.6% | -25.8% | -48.8% | -61.6% | -61.0% | -24.1% | -18.4% | -7.7% | -8.3% | -22.2% | |
| Quick Ratio | 1.59 | 1.43 | 1.64 | 1.59 | 1.38 | 1.35 | 1.32 | 1.28 | 2.12 | 2.48 | 2.53 | 2.48 | 2.50 | 2.21 | 1.82 | 1.83 | 3.43 | 4.30 | 4.79 | 4.62 | 4.50 |
| — | +5.7% | +23.7% | +23.9% | -34.7% | -45.7% | -47.7% | -48.4% | -15.3% | +12.2% | +38.7% | +35.9% | -27.0% | -48.5% | -61.9% | -60.4% | -23.8% | -18.1% | -8.4% | -11.1% | -25.0% | |
| Interest Coverage | 60.48 | 106.83 | 87.94 | 82.12 | 75.96 | 52.30 | 33.83 | 44.12 | 38.74 | 40.13 | 29.80 | 51.24 | 50.06 | 28.00 | 15.02 | 29.34 | 32.78 | 17.02 | 7.69 | 2.36 | 25.72 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying DXCM stock.
DexCom, Inc.'s current P/E is 37.5x. The average P/E over the last 4 quarters is 26.4x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
DexCom, Inc.'s current operating margin is 19.6%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking DexCom, Inc.'s business trajectory between earnings reports.